Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Amarin Corp. Plc (NASDAQ: AMRN).

Full DD Report for AMRN

You must become a subscriber to view this report.


Recent News from (NASDAQ: AMRN)

Institutional Top Ideas Series: Opaleye Management
In the last entry of this series, we took a look at top ideas from Ra Capital Management, the best performing fund we´ve come across so far with heavily concentrated positions in their top ideas. Going forward, I hope to continue to delve into the portfolios of successful hedge funds ...
Source: SeekingAlpha
Date: May, 17 2018 01:52
Amarin's (AMRN) CEO John Thero on Q1 2018 Results - Earnings Call Transcript
Amarin Corporation PLC (AMRN) Q1 2018 Earnings Conference Call May 2, 2018 07:30 am ET Executives John Thero - President and Chief Executive Officer Craig Granowitz - SVP, Chief Medical Officer Mike Kalb - SVP, Chief Financial Officer Elisabeth Schwartz - Senior Director, Inves...
Source: SeekingAlpha
Date: May, 02 2018 17:16
Amarin Corporation PLC 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Amarin Corporation PLC in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: May, 02 2018 09:30
Amarin Q1 revenues up 27%; shares ahead 3% premarket
Amarin ( AMRN ) Q1 results : Revenues: $43.9M (+26.9%); Product revenue: $43.8M (+27.7%); Licensing revenue: $0.1M (-66.7%). More news on: Amarin Corporation PLC, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: May, 02 2018 08:19
Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations
REDUCE-IT Study On-Track for Reporting Top-Line Results by the End of Q3 2018 Management to Host Conference Call at 7:30 a.m. ET Today BEDMINSTER, N.J. and DUBLIN, Ireland, May 02, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focu...
Source: GlobeNewswire
Date: May, 02 2018 05:00
Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018
BEDMINSTER, N.J. and DUBLIN, Ireland, April 26, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a confere...
Source: GlobeNewswire
Date: April, 26 2018 05:00
Amarin Announces Promotion of Aaron Berg to Position of Chief Commercial Officer
BEDMINSTER, N.J., and DUBLIN, Ireland, April 23, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular (CV) health, today announced that Aaron Berg has been p...
Source: GlobeNewswire
Date: April, 23 2018 05:00
New Research: Key Drivers of Growth for Amarin, Korea Electric Power, Star Bulk Carriers, 1-800 FLOWERS.COM, Clementia Pharmaceuticals, and Bank of Nova Scotia - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, April 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Amarin Corporation PLC (NASDAQ:AMRN), Korea Electric Power Corporation (...
Source: GlobeNewswire
Date: April, 13 2018 08:20
After Hours Gainers / Losers (04/12/2018)
Top gainers: NWL +4.8% . AVGO +4.4% . AMRN   +3.2% . SAGE   +2.5% . GERN   +1.5% . More news on: Newell Brands Inc., Broadcom Limited, Amarin Corporation PLC, Stocks on the move, , News on ETFs, Read more ...
Source: SeekingAlpha
Date: April, 12 2018 17:36
Amarin Sponsors Three Scientific Presentations Scheduled for National Lipid Association Scientific Sessions
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health,  is supporting the presentation of three ac...
Source: GlobeNewswire
Date: April, 12 2018 16:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-183.253.283.353.241,381,352
2018-05-173.183.263.273.161,653,745
2018-05-163.173.193.213.17758,410
2018-05-153.213.1953.2553.15945,160
2018-05-143.153.213.243.151,303,071

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-18337,698718,78046.9821Short
2018-05-17285,729635,13844.9869Short
2018-05-16277,714595,22946.6567Short
2018-05-15236,800580,69340.7789Short
2018-05-14244,907780,72731.3691Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AMRN.


About Amarin Corp. Plc (NASDAQ: AMRN)

Logo for Amarin Corp. Plc (NASDAQ: AMRN)

Not available

 

Contact Information

 

 

Current Management

  • Rick Stewart / CEO
  • Mike Coffee / President, COO
  • Nigel Bell / CFO
  • Jonathan Lamb / Secretary

Current Share Structure

  • Market Cap: $924,790,041 - 05/11/2018
  • Issue and Outstanding: 293,584,140 - 04/30/2018

 


Recent Filings from (NASDAQ: AMRN)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 20 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 27 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 01 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: January, 31 2018

 

 


Daily Technical Chart for (NASDAQ: AMRN)

Daily Technical Chart for (NASDAQ: AMRN)


Stay tuned for daily updates and more on (NASDAQ: AMRN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: AMRN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AMRN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of AMRN and does not buy, sell, or trade any shares of AMRN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/